Toggle navigation
Home
Search
Services
Blog
Contact
About
Clinical Evaluation of Biological Response Modifiers
Neefe, John R.
Georgetown University, Washington, DC, United States
Search 6 grants from John Neefe
Search grants from Georgetown University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Effects of sphingolipids on nutrient transporter expression and bioenergetics
Agonists of the RIG-I Innate Immune Pathway
Detection of Salvageable Myocardium by Contrast MRI
Policy Change Effects on Pregnancy Outcomes
Molecular Basis for Schistosome Reproductive Development
Recently added grants:
Determination of the Interactome between Haemophilus ducreyi and the Human Host.
Mechanisms for Radiation Damage to DNA: LET Effects
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
Whole-of-Community Systems Intervention for Youth Population Physical Activity
Surgery triggered immune response and liver metastases
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007437-001010
Application #
3608506
Study Section
Project Start
1980-09-30
Project End
Budget Start
1985-12-31
Budget End
1986-04-30
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Georgetown University
Department
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Related projects
NIH 1986
N01 CM
Clinical Evaluation of Biological Response Modifiers
Neefe, John R. / Georgetown University
NIH 1985
N01 CM
Clinical Evaluation of Biological Response Modifiers
Neefe, John R. / Georgetown University
Publications
Neefe, J R; Phillips, E A; Treat, J
(1986)
Augmentation of natural immunity and correlation with tumor response in melanoma patients treated with human lymphoblastoid interferon.
Diagn Immunol 4:299-305
Comments
Be the first to comment on this grant